Paul Brannelly's Net Worth
$8.66 Million
Who is Paul Brannelly?
Paul Brannelly has an estimated net worth of $8.66 Million. This is based on reported shares across multiple companies, which include Sirtris Pharmaceuticals, Inc., COLLEGIUM PHARMACEUTICAL, INC, and Karyopharm Therapeutics Inc..
SEC CIK
Paul Brannelly's CIK is 0001394936
Past Insider Trading and Trends
2016 was Paul Brannelly's most active year for acquiring shares with 8 total transactions. Paul Brannelly's most active month to acquire stocks was the month of December. 2008 was Paul Brannelly's most active year for disposing of shares, totalling 49 transactions. Paul Brannelly's most active month to dispose stocks was the month of December. 2017 saw Paul Brannelly paying a total of $110,166.08 for 60,532 shares, this is the most they've acquired in one year. In 2021 Paul Brannelly cashed out on 8,491 shares for a total of $220,341.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sirtris Pharmaceuticals, Inc. No price found
VP Finance, Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +86.14% | 14.64K |
$0.42 | $6,150.06 | 31.64K |
May 28
| |||
Form 4
| +41.67% | 5K |
—
|
—
| 17K |
Feb 22
| |||
Form 4
| -35.30% | -6.55K |
$12.29 | -$80,438.38 | 12K |
Scheduled
|
Feb 6
| ||
Form 4
| -26.09% | -6.55K |
$12.92 | -$84,588.88 | 18.55K |
Scheduled
|
Jan 24
| ||
Form 4
| +91.64% | 12K |
—
|
—
| 25.09K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $37.19
Executive Vice President & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.79% | -8.49K |
$25.95 | -$220,341.45 | 215.43K |
Feb 10
| |||
Form 4/A
| +28.87% | 50.16K |
—
|
—
| 223.92K |
Jan 19
| |||
Form 4
| +28.87% | 50.16K |
—
|
—
| 223.92K |
Jan 19
| |||
Form 4
| -0.86% | -1.51K |
$18.89 | -$28,618.35 | 173.76K |
Aug 10
| |||
Form 4
| -2.24% | -4.03K |
$21.62 | -$87,020.50 | 175.27K |
Feb 10
| |||
Form 4
| +18.60% | 28.13K |
—
|
—
| 179.3K |
Feb 5
| |||
Form 4
| -0.14% | -214.00 |
$21.56 | -$4,613.84 | 151.17K |
Jan 21
| |||
Form 4
| -0.47% | -720.00 |
$10.14 | -$9,846.20 | 151.39K |
Jul 26 - Aug 9
| |||
Form 4
| -0.12% | -181.00 |
$10.35 | -$1,873.35 | 152.11K |
Jul 19
| |||
Form 4
| -1.74% | -2.69K |
$14.39 | -$38,752.27 | 152.29K |
Feb 8
| |||
Form 4
| +26.02% | 32K |
—
|
—
| 154.98K |
Jan 25
| |||
Form 4
| -0.17% | -214.00 |
$15.76 | -$3,372.64 | 122.98K |
Jan 18
| |||
Form 4
| -0.48% | -599.00 |
$18.03 | -$10,799.97 | 123.19K |
Aug 23
| |||
Form 4
| +0.29% | 358 |
$17.99 | $4,890.61 | 123.79K |
Jul 27 - Aug 3
| |||
Form 4
| -7.49% | -10.00K |
$27.92 | -$279,165.00 | 123.44K |
Scheduled
|
Jun 21
| ||
Form 4
| -0.89% | -1.20K |
$21.77 | -$26,058.69 | 133.44K |
Feb 26
| |||
Form 4
| -0.16% | -214.00 |
$23.38 | -$5,003.32 | 134.63K |
Feb 5
| |||
Form 4
| +21.70% | 24.04K |
$10.17 | $10,617.48 | 134.85K |
Dec 14 - Jan 26
| |||
Form 4
| +0.52% | 576 |
$11.50 | $5,747.60 | 110.8K |
Jul 28 - Aug 4
| |||
Form 4
| +9.98% | 10K |
$9.18 | $91,800.00 | 110.23K |
May 12
| |||
Form 4
| -0.39% | -388.00 |
$14.95 | -$5,800.60 | 100.23K |
Mar 17
| |||
Form 4
| +20.70% | 17.26K |
$10.08 | $10,140.48 | 100.61K |
Jan 27 - Feb 10
| |||
Form 4
| +1.19% | 983 |
$10.31 | $10,134.73 | 83.36K |
Jul 29
| |||
Form 4
| +1.35% | 1.1K |
$16.89 | $18,579.00 | 82.38K |
May 20
| |||
Form 4
| +1.12% | 900 |
$16.00 | $14,400.00 | 81.28K |
May 18
| |||
Form 4
| +1.26% | 1K |
$15.46 | $15,460.00 | 80.38K |
May 17
| |||
Form 4
| +1.02% | 800 |
$15.73 | $12,584.00 | 79.38K |
May 16
| |||
Form 4
| +1.55% | 1.2K |
$15.02 | $18,024.00 | 78.58K |
May 13
| |||
Form 4
| +6.78% | 4.91K |
—
|
—
| 77.38K |
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karyopharm Therapeutics Inc. (KPTI) Snapshot price: $0.77
SVP, FINANCE & ADMIN, TREAS
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.07% | 700 |
$25.95 | $18,165.00 | 66.14K |
May 15
| |||
Form 4
| +1.24% | 800 |
$26.93 | $21,544.00 | 65.44K |
May 14
| |||
Form 4
| +1.57% | 1K |
$28.06 | $28,057.40 | 64.64K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||